CDK4/PROTAC

货号			产品名	纯度
A1550123	现货	促	XY028-140 XY028-140是一种 PROTAC 连接体，能够选择性降解 CDK 蛋白，具有抗癌应用的潜力。	98%
A1250161	现货		XY028-133 XY028-133 (example 14) is a PROTAC-based CDK4/6 degrader with anti-tumor activity.	98%
A1365583			BSJ-04-132 BSJ-04-132 is a potent and selective Ribociclib-based CDK4 degrader (PROTAC), with IC50s of 50.6 nM and 30 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-04-132 does not induce CDK6 and IKZF1/3 degradation. BSJ-04-132 has anti-cancer activity.	98%
A1365582			BSJ-03-204 BSJ-03-204 is a potent and selective Palbociclib-based CDK4/6 dual degrader (PROTAC), with IC50s of 26.9 nM and 10.4 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-03-204 does not induce IKZF1/3 degradation and has anti-cancer activity.	98%
A1601245			CDK4/6-IN-11	98%

货号

产品名

纯度

A1550123

现货

促

XY028-140

XY028-140是一种 PROTAC 连接体，能够选择性降解 CDK 蛋白，具有抗癌应用的潜力。

98%

A1250161

现货

XY028-133

XY028-133 (example 14) is a PROTAC-based CDK4/6 degrader with anti-tumor activity.

98%

A1365583

BSJ-04-132

BSJ-04-132 is a potent and selective Ribociclib-based CDK4 degrader (PROTAC), with IC50s of 50.6 nM and 30 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-04-132 does not induce CDK6 and IKZF1/3 degradation. BSJ-04-132 has anti-cancer activity.

98%

A1365582

BSJ-03-204

BSJ-03-204 is a potent and selective Palbociclib-based CDK4/6 dual degrader (PROTAC), with IC50s of 26.9 nM and 10.4 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-03-204 does not induce IKZF1/3 degradation and has anti-cancer activity.

98%

A1601245

CDK4/6-IN-11

98%